Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure
Trial · NCT03759392
Adverse events142
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
121 to 140 of 142
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Complications of transplanted heart | Injury, poisoning and procedural complications | Omecamtiv Mecarbil | 0 | 185 | |
| serious | Complications of transplanted heart | Injury, poisoning and procedural complications | Placebo | 1 | 91 | |
| serious | Diabetes mellitus | Metabolism and nutrition disorders | Omecamtiv Mecarbil | 1 | 185 | |
| serious | Diabetes mellitus | Metabolism and nutrition disorders | Placebo | 0 | 91 | |
| serious | Gout | Metabolism and nutrition disorders | Omecamtiv Mecarbil | 0 | 185 | |
| serious | Gout | Metabolism and nutrition disorders | Placebo | 1 | 91 | |
| serious | Fluid retention | Metabolism and nutrition disorders | Omecamtiv Mecarbil | 1 | 185 | |
| serious | Fluid retention | Metabolism and nutrition disorders | Placebo | 0 | 91 | |
| serious | Arthritis | Musculoskeletal and connective tissue disorders | Omecamtiv Mecarbil | 1 | 185 | |
| serious | Arthritis | Musculoskeletal and connective tissue disorders | Placebo | 0 | 91 | |
| serious | Flank pain | Musculoskeletal and connective tissue disorders | Omecamtiv Mecarbil | 0 | 185 | |
| serious | Flank pain | Musculoskeletal and connective tissue disorders | Placebo | 1 | 91 | |
| serious | Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Omecamtiv Mecarbil | 1 | 185 | |
| serious | Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 91 | |
| serious | Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | Omecamtiv Mecarbil | 0 | 185 | |
| serious | Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 91 | |
| serious | Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Omecamtiv Mecarbil | 0 | 185 | |
| serious | Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 91 | |
| serious | Acute kidney injury | Renal and urinary disorders | Omecamtiv Mecarbil | 1 | 185 | |
| serious | Acute kidney injury | Renal and urinary disorders | Placebo | 0 | 91 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03759392/events?page=7